tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market
SLNO
Soleno Therapeutics
RESEARCH TOOLSreports
Want to see SLNO full AI Analyst Report?

Soleno Therapeutics (SLNO) Ratios

927 Followers

Soleno Therapeutics Ratios

SLNO's free cash flow for Q4 2025 was $0.99. For the 2025 fiscal year, SLNO's free cash flow was decreased by $ and operating cash flow was $0.49. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.80 5.80 15.68 14.89 2.14
Quick Ratio
 5.55 5.55 15.68 14.89 2.14
Cash Ratio
 1.14 1.14 4.69 14.75 2.00
Solvency Ratio
 0.20 0.20 -2.02 -1.60 -1.37
Operating Cash Flow Ratio
 0.77 0.76 -3.69 -2.17 -2.84
Short-Term Operating Cash Flow Coverage
 64.71 64.46 0.00 0.00 0.00
Net Current Asset Value
$ 242.10M$ 242.10M$ 208.03M$ 148.17M$ -502.00K
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.16 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.22 <0.01 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 0.18 <0.01 0.01
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.17 0.00 0.00
Financial Leverage Ratio
 1.25 1.25 1.35 1.15 2.56
Debt Service Coverage Ratio
 4.58 4.58 -751.65 0.00 0.00
Interest Coverage Ratio
 1.88 2.73 -812.43 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.03 0.00 0.00
Interest Debt Per Share
 0.15 0.15 1.32 0.02 0.02
Net Debt to EBITDA
 -2.38 -2.38 0.20 4.57 0.65
Profitability Margins
Gross Profit Margin
98.58%98.58%0.00%0.00%0.00%
EBIT Margin
13.85%13.85%0.00%0.00%0.00%
EBITDA Margin
14.91%14.91%0.00%0.00%0.00%
Operating Profit Margin
5.39%7.85%0.00%0.00%0.00%
Pretax Profit Margin
10.97%10.97%0.00%0.00%0.00%
Net Profit Margin
10.97%10.97%0.00%0.00%0.00%
Continuous Operations Profit Margin
10.97%10.97%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
203.45%139.73%93.70%94.21%98.65%
Return on Assets (ROA)
3.71%3.71%-53.13%-21.58%-90.83%
Return on Equity (ROE)
5.90%4.64%-71.74%-24.75%-232.58%
Return on Capital Employed (ROCE)
2.04%2.98%-60.11%-24.46%-127.17%
Return on Invested Capital (ROIC)
2.04%2.97%-60.01%-24.42%-126.15%
Return on Tangible Assets
3.74%3.74%-54.25%-22.68%-152.28%
Earnings Yield
0.74%0.85%-9.74%-5.87%-28.95%
Efficiency Ratios
Receivables Turnover
 6.75 6.75 0.00 0.00 0.00
Payables Turnover
 0.22 0.22 0.00 0.00 0.00
Inventory Turnover
 0.18 0.18 0.00 0.00 0.00
Fixed Asset Turnover
 80.14 80.14 0.00 0.00 0.00
Asset Turnover
 0.34 0.34 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.48 0.67 0.00 0.00 0.00
Cash Conversion Cycle
 404.07 404.07 0.00 0.00 0.00
Days of Sales Outstanding
 54.07 54.07 0.00 0.00 0.00
Days of Inventory Outstanding
 2.03K 2.03K 0.00 0.00 0.00
Days of Payables Outstanding
 1.68K 1.68K 0.00 0.00 0.00
Operating Cycle
 2.09K 2.09K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 0.88 0.88 -1.72 -1.51 -2.47
Free Cash Flow Per Share
 0.88 0.88 -1.73 -1.51 -2.48
CapEx Per Share
 <0.01 <0.01 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 643.51 641.07 -316.95 0.00 -1.60K
Capital Expenditure Coverage Ratio
 643.51 641.07 -316.95 0.00 -1.60K
Operating Cash Flow Coverage Ratio
 17.46 17.40 -1.31 -61.89 -134.07
Operating Cash Flow to Sales Ratio
 0.25 0.25 0.00 0.00 0.00
Free Cash Flow Yield
1.72%1.90%-3.84%-3.76%-25.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 134.20 117.86 -10.27 -17.03 -3.45
Price-to-Sales (P/S) Ratio
 14.32 12.93 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 6.23 5.47 7.37 4.21 8.03
Price-to-Free Cash Flow (P/FCF) Ratio
 58.13 52.69 -26.05 -26.62 -4.00
Price-to-Operating Cash Flow Ratio
 59.68 52.61 -26.14 -26.62 -4.00
Price-to-Earnings Growth (PEG) Ratio
 0.53 -1.08 -0.12 0.96 0.07
Price-to-Fair Value
 6.23 5.47 7.37 4.21 8.03
Enterprise Value Multiple
 93.69 84.37 -10.20 -13.35 -3.11
Enterprise Value
 2.66B 2.39B 1.77B 494.53M 68.68M
EV to EBITDA
 93.76 84.37 -10.20 -13.35 -3.11
EV to Sales
 13.98 12.58 0.00 0.00 0.00
EV to Free Cash Flow
 56.74 51.25 -25.55 -19.83 -3.30
EV to Operating Cash Flow
 56.65 51.17 -25.63 -19.83 -3.31
Tangible Book Value Per Share
 8.37 8.37 5.93 9.02 -0.04
Shareholders’ Equity Per Share
 8.46 8.46 6.10 9.55 1.23
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 3.58 3.58 0.00 0.00 0.00
Net Income Per Share
 0.39 0.39 -4.38 -2.36 -2.87
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.79 0.79 1.00 1.00 1.00
Research & Development to Revenue
 0.21 0.21 0.00 0.00 0.00
SG&A to Revenue
 0.69 0.69 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.19 0.24 0.00 0.00 0.00
Income Quality
 2.25 2.24 0.39 0.64 0.86
Currency in USD